The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Siamak Daneshmand
Stock and Other Ownership Interests - Taris
Honoraria - Allergan (I); AstraZeneca; Bausch and Lomb (I); Bristol-Myers Squibb; CG Oncology; enGene; Ferring; ImmunityBio; Johnson & Johnson; Lilly; pacific edge; Pfizer; Photocure; Protara Therapeutics; Storz; Urogen pharma
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bristol-Myers Squibb/Pfizer; CG Oncology; enGene; Ferring; ImmunityBio; Johnson & Johnson/Janssen; pacific edge; Pfizer; Photocure; Taris; Urogen pharma; UroToday
Research Funding - Photocure
Travel, Accommodations, Expenses - Janssen Oncology; Photocure
 
Paras Shah
No Relationships to Disclose
 
Timothy Lyon
Consulting or Advisory Role - enGene; UroGen pharma
Research Funding - CG Oncology; Ferring; ImmunityBio; Johnson & Johnson; Merck; Protara Therapeutics
 
Ankeet Shah
Employment - Duke University Health System
Honoraria - Bayer
Consulting or Advisory Role - enGene; Prokarium
 
Trinity Bivalacqua
Honoraria - Ferring; Janssen; UROGENE
Consulting or Advisory Role - Urogen pharma
 
Amy Luckenbaugh
Consulting or Advisory Role - enGene
 
Colin Dinney
Stock and Other Ownership Interests - CG Oncology
Consulting or Advisory Role - CG Oncology
Research Funding - CG Oncology
Patents, Royalties, Other Intellectual Property - Ferring
 
Mark Tyson
Consulting or Advisory Role - AstraZeneca; enGene; Ferring; ImmunityBio; Protara Therapeutics
Research Funding - AstraZeneca (Inst); CG Oncology (Inst); enGene (Inst); Ferring (Inst); ImmunityBio (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); NCI (Inst); pacific edge (Inst); Protara Therapeutics (Inst); Seagen (Inst); SWOG (Inst); Urogen pharma (Inst)